128 related articles for article (PubMed ID: 2499202)
21. A Trypanosoma brucei mutant resistant to alpha-difluoromethylornithine.
Phillips MA; Wang CC
Mol Biochem Parasitol; 1987 Jan; 22(1):9-17. PubMed ID: 3100950
[TBL] [Abstract][Full Text] [Related]
22. The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei.
Lanteri CA; Tidwell RR; Meshnick SR
Antimicrob Agents Chemother; 2008 Mar; 52(3):875-82. PubMed ID: 18086841
[TBL] [Abstract][Full Text] [Related]
23. Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models.
Bacchi CJ; Nathan HC; Clarkson AB; Bienen EJ; Bitonti AJ; McCann PP; Sjoerdsma A
Am J Trop Med Hyg; 1987 Jan; 36(1):46-52. PubMed ID: 3101528
[TBL] [Abstract][Full Text] [Related]
24. Studies on lipidomimetic derivatives of alpha-difluoromethylornithine (DFMO) to enhance the bioavailability in a Trypanosoma B. brucei murine trypanosomiasis model.
Loiseau PM; Czok M; Chauffert O; Bourass J; Letourneux Y
Parasite; 1998 Sep; 5(3):239-46. PubMed ID: 9772723
[TBL] [Abstract][Full Text] [Related]
25. Analysis by flow cytometry of DNA synthesis during the life cycle of African trypanosomes.
Shapiro SZ; Naessens J; Liesegang B; Moloo SK; Magondu J
Acta Trop; 1984 Dec; 41(4):313-23. PubMed ID: 6152113
[TBL] [Abstract][Full Text] [Related]
26. [Action of drugs tested in an acellular medium and in mice infected with Trypanosoma brucei brucei].
Bouteille B; Darde ML; Pestre-Alexandre M
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):533-42. PubMed ID: 3143489
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine in African trypanosomes and Pneumocystis carinii as a basis of chemotherapy: biochemical and clinical aspects.
McCann PP; Bacchi CJ; Clarkson AB; Bey P; Sjoerdsma A; Schecter PJ; Walzer PD; Barlow JL
Am J Trop Med Hyg; 1986 Nov; 35(6):1153-6. PubMed ID: 3098121
[TBL] [Abstract][Full Text] [Related]
28. Trypanosoma brucei: analysis of cytoplasmic Ca2+ during differentiation of bloodstream stages in vitro.
Stojdl DF; Clarke MW
Exp Parasitol; 1996 Jun; 83(1):134-46. PubMed ID: 8654542
[TBL] [Abstract][Full Text] [Related]
29. The bloodstream differentiation-division of Trypanosoma brucei studied using mitochondrial markers.
Tyler KM; Matthews KR; Gull K
Proc Biol Sci; 1997 Oct; 264(1387):1481-90. PubMed ID: 9364788
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of dipalmitoylphosphatidylcholine liposome against African trypanosomes.
Kuboki N; Yokoyama N; Kojima N; Sakurai T; Inoue N; Sugimoto C
J Parasitol; 2006 Apr; 92(2):389-93. PubMed ID: 16729700
[TBL] [Abstract][Full Text] [Related]
31. The in vitro differentiation of pleomorphic Trypanosoma brucei from bloodstream into procyclic form requires neither intermediary nor short-stumpy stage.
Bass KE; Wang CC
Mol Biochem Parasitol; 1991 Feb; 44(2):261-70. PubMed ID: 2052026
[TBL] [Abstract][Full Text] [Related]
32. Trypanocidal action of bisphosphonium salts through a mitochondrial target in bloodstream form Trypanosoma brucei.
Alkhaldi AAM; Martinek J; Panicucci B; Dardonville C; Zíková A; de Koning HP
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):23-34. PubMed ID: 27054061
[TBL] [Abstract][Full Text] [Related]
33. Studies on the efficacy of DL-alpha-difluoromethylornithine (DFMO) associated with bleomycin and suramin for treatment of mice infected with metacyclic forms of Trypanosoma brucei brucei.
Demey F
Vet Res Commun; 1987; 11(3):271-4. PubMed ID: 2442883
[TBL] [Abstract][Full Text] [Related]
34. Further studies on difluoromethylornithine in African trypanosomes.
McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
[TBL] [Abstract][Full Text] [Related]
35. Differential mitochondrial gene expression between slender and stumpy bloodforms of Trypanosoma brucei.
Feagin JE; Jasmer DP; Stuart K
Mol Biochem Parasitol; 1986 Sep; 20(3):207-14. PubMed ID: 2429179
[TBL] [Abstract][Full Text] [Related]
36. Deletion of a novel protein kinase with PX and FYVE-related domains increases the rate of differentiation of Trypanosoma brucei.
Vassella E; Krämer R; Turner CM; Wankell M; Modes C; van den Bogaard M; Boshart M
Mol Microbiol; 2001 Jul; 41(1):33-46. PubMed ID: 11454198
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of long slender (LS) to short stumpy (SS) transformation in the African trypanosomes.
Seed JR; Sechelski JB
J Protozool; 1989; 36(6):572-7. PubMed ID: 2600880
[TBL] [Abstract][Full Text] [Related]
38. Synergistic activity of 5-substituted 2-nitroimidazoles (Ro 15-0216 and benznidazole) and DL-alpha-difluoromethylornithine on Trypanosoma brucei brucei.
Zweygarth E; Kaminsky R; Sayer PD; van Nieuwenhove S
Ann Soc Belg Med Trop; 1990 Dec; 70(4):269-79. PubMed ID: 2291692
[TBL] [Abstract][Full Text] [Related]
39. Metabolic differentiation of bloodstream forms of Trypanosoma brucei brucei into procyclic forms. Effect of hydroxyurea, arabinosyl adenine, and serum omission.
Markos A; Blahůsková A; Kalous M; Bysková E; Byska K; Nohýnková E
Folia Parasitol (Praha); 1989; 36(3):225-38. PubMed ID: 2555290
[TBL] [Abstract][Full Text] [Related]
40. DL-alpha-difluoromethylornithine (DFMO)-Berenil combination: therapeutic and prophylactic activity against Trypanosoma brucei brucei infection in mice.
Onyeyili PA; Egwu GO; Zaria LT; Orjiude BA
Rev Elev Med Vet Pays Trop; 1991; 44(4):443-5. PubMed ID: 1843826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
